Chronic myeloid leukemia (CML) is a myeloproliferative disorder characterized by a genetic translocation between chromosomes 9 and 22, leading to the generation of the hybrid protein BCR-ABL with tyrosine kinase activity. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.